5 hasil untuk "Rowe, Joshua"
Menampilkan 1–5 · 0,65 detik · RSS
-
Artikel Jurnal Teks lengkap
Mass Balance and Metabolism of (14)C‐Atogepant in Healthy Male Participants: Findings of a Phase 1 Clinical Trial
Atogepant, a calcitonin gene‐related peptide (CGRP) receptor antagonist, is approved for the preventive treatment of migraine in adults. This open‐label, phase 1 study examined radiolabeled atogepant ((14)C‐atogepant) metabolism, elimination, and mass balance after a single dose (50 mg, ~200 μCi)…
-
Artikel Jurnal Teks lengkap
Relative skeletal distribution of proliferating marrow in the adult dog determined using 3′‐deoxy‐3′‐[(18)F]fluorothymidine
3′‐deoxy‐3′‐[(18)F]fluorothymidine ((18)FLT) is a radiopharmaceutical tracer used with positron emission tomography (PET), often in combination with computed tomography (CT), to image DNA synthesis, and thus, cellular proliferation. Characteristic accumulation of the tracer within haematopoietic…
-
Artikel Jurnal Teks lengkap
Collision activity during training increases total energy expenditure measured via doubly labelled water
PURPOSE: Collision sports are characterised by frequent high-intensity collisions that induce substantial muscle damage, potentially increasing the energetic cost of recovery. Therefore, this study investigated the energetic cost of collision-based activity for the first time across any sport…
-
Artikel Jurnal Teks lengkap
Maternal Protein Restriction and Branched-Chain Amino Acid Supplementation Differentially Affect Maternal Energy Balance and Impair Offspring Growth
Background: The increasing prevalence of low-birth-weight (LBW) offspring from obese mothers underscores the need for dietary strategies to mitigate the transgenerational propagation of metabolic diseases. Objectives: We determined whether dietary protein restriction under obesogenic conditions…
-
Artikel Jurnal Teks lengkap
A Human Mass Balance and Metabolism Study of [(14)C]‐Ubrogepant in Healthy Male Adults
Ubrogepant is a calcitonin gene–related peptide receptor antagonist approved for the acute treatment of migraine with or without aura in adults. The mass balance and metabolism of ubrogepant was evaluated in six healthy male adults administered a single oral dose of [(14)C]‐ubrogepant 50 mg (∼200…